Fløtten, Ø., Grønberg, B. H., Bremnes, R., Amundsen, T., Sundstrøm, S., Rolke, H., . . . von Plessen, C. (2012). Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group. Nature Publishing Group.
Chicago Style citaatFløtten, Ø, et al. Vinorelbine and Gemcitabine Vs Vinorelbine and Carboplatin As First-line Treatment of Advanced NSCLC. A Phase III Randomised Controlled Trial By the Norwegian Lung Cancer Study Group. Nature Publishing Group, 2012.
MLA citatieFløtten, Ø, et al. Vinorelbine and Gemcitabine Vs Vinorelbine and Carboplatin As First-line Treatment of Advanced NSCLC. A Phase III Randomised Controlled Trial By the Norwegian Lung Cancer Study Group. Nature Publishing Group, 2012.